Literature DB >> 12539798

Time control, catecholamines and back pain among young nurses.

Achim Elfering1, Simone Grebner, Norbert K Semmer, Hans Gerber.   

Abstract

OBJECTIVES: This study had two objectives. First, it addressed concern with the contribution of work stressors and resources to the development of back pain, over and above the influence of biomechanical work factors. Second, using recent models about the role of the sympathetic-adrenal medullar system in musculoskeletal problems as its basis, it tested whether low-back pain is associated with higher levels of catecholamines.
METHODS: Altogether 114 nurses filled out a questionnaire in their first year of practice and again one year later. In addition, in a subsample of 24 nurses studied intensively at follow-up, urinary catecholamines were assessed at noon, before the end of work, in the evening, and at corresponding times on a day off. Daily stressful experiences and daily mood were also recorded.
RESULTS: With control for baseline pain, biomechanical workload, and other potentially confounding variables, time control at the beginning of the study predicted low-back pain a year later. In the subsample, the epinephrine and norepinephrine levels were higher in those reporting more frequent episodes of back pain, the largest differences occurring at the end of work. In addition, control over stressful events at work was lower in this group.
CONCLUSIONS: Time control is a risk factor for low-back pain among nurses beyond the influence of physical work load. Low control at work may increase the activity of the sympathetic-adrenal medullar system, which seems to play an important role in the development of musculoskeletal pain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12539798     DOI: 10.5271/sjweh.690

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  8 in total

Review 1.  Psychosocial factors at work in relation to low back pain and consequences of low back pain; a systematic, critical review of prospective cohort studies.

Authors:  J Hartvigsen; S Lings; C Leboeuf-Yde; L Bakketeig
Journal:  Occup Environ Med       Date:  2004-01       Impact factor: 4.402

Review 2.  Work-related outcome assessment instruments.

Authors:  Achim Elfering
Journal:  Eur Spine J       Date:  2005-11-23       Impact factor: 3.134

Review 3.  Janus molecule I: dichotomous effects of COMT in neuropathic vs nociceptive pain modalities.

Authors:  S K Segall; W Maixner; I Belfer; T Wiltshire; Z Seltzer; L Diatchenko
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-05       Impact factor: 4.388

4.  Relationship Between Low Back Pain With Quality of Life, Depression, Anxiety and Stress Among Emergency Medical Technicians.

Authors:  Abolfazl Rahimi; Hossein Vazini; Fatemeh Alhani; Monireh Anoosheh
Journal:  Trauma Mon       Date:  2015-05-25

5.  Work-Family Conflict, Task Interruptions, and Influence at Work Predict Musculoskeletal Pain in Operating Room Nurses.

Authors:  Marina Nützi; Patricia Koch; Heiner Baur; Achim Elfering
Journal:  Saf Health Work       Date:  2015-08-18

6.  Interaction between occupational physical burdens and low job control on musculoskeletal pain: Analysis of the 5th Korean Working Environment Survey.

Authors:  Jongin Lee; Hyoung-Ryoul Kim; Dong-Wook Lee; Mo-Yeol Kang
Journal:  J Occup Health       Date:  2021-01       Impact factor: 2.708

7.  Job characteristics in nursing and cognitive failure at work.

Authors:  Achim Elfering; Simone Grebner; Anna Dudan
Journal:  Saf Health Work       Date:  2011-06-30

8.  Development of a screening tool predicting the transition from acute to chronic low back pain for patients in a GP setting: protocol of a multinational prospective cohort study.

Authors:  Markus Melloh; Nikolaus Aebli; Achim Elfering; Christoph Röder; Thomas Zweig; Thomas Barz; Peter Herbison; Paul Hendrick; Suraj Bajracharya; Kirsten Stout; Jean-Claude Theis
Journal:  BMC Musculoskelet Disord       Date:  2008-12-19       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.